Clinical Trial Update: Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the efficacy and safety of T2345 in patients with glaucoma or ocular hypertension has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• T2345

Snippet

Sponsor: Laboratoires Thea | Conditions: Glaucoma | Phase 3 | Status: COMPLETED | Results posted: 2014-11-19